The semaglutide market is valued at USD 30.53 billion in 2025 and is expected to grow to USD 90.3 billion in 2035, growing at a CAGR of 11.45% during the forecast period. Research by Deepa Pandey, Senior Research Analyst.
For Any Query
Please drop a mail to the Precedence Research team for your queries